Pharmaceutical Care in Community Pharmacy in the Republic of Macedonia. a Compared Study with Eu Countries

نویسنده

  • Merita Dauti
چکیده

In recent years in the Republic of Macedonia, the pharmaceutical legislation has undergone permanent modifications in terms of the unification with the European legislation. In essence, the establishment of certain new criteria and the amendment of the whole set of standards uniform in the EU, will undoubtedly help in increasing the quality of pharmaceutical services and will guarantee the patients’ health. The Republic of Macedonia has a social healthcare system. Pharmacies are in private ownership but healthcare authorities regulate the prices of medications and the number of pharmacies across the whole territory. Many of these pharmacies have concluded regular collaboration contracts with the Health Insurance Fund of the Republic of Macedonia. The services provided by these pharmacies consist mainly in the distribution of prescribed medications and OTC preparations, nutrition products, medication usage recommendations, effects and anti-effects, etc. This paper aims at reviewing the existing legislation, the reforms carried out in time, the existing status of the pharmaceutical community in Macedonia, while comparing it with some of the countries of the EU. Special emphasis will be put on reviewing the possibilities for better inclusion of pharmacists in the healthcare system so that they can become participants in the healthcare provision teams as well as get included in the activities for the prevention of different diseases. In this respect, lots of research in international literature, including scientific articles, presentations, technical reports, and other studies has been carried out in order to present the experiences from the EU member states.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pharmacy practice in the Republic of Macedonia

As part of wider reforms within the pharmaceutical sector, the pharmaceutical care concept has been introduced in the Republic of Macedonia. This article provides discussion on current opportunities and challenges which pharmacy practice face in Macedonia. The emphasis is on three prerequisites for the implementation of pharmaceutical care including: organization of pharmaceutical services, leg...

متن کامل

Development of Pharmacy Practice in European Countries—The Polish Perspective

Polish pharmacy practice and the distribution of medicinal products in some European countries are still going through a significant transformation. Changes postulated by the pharmacists should strengthen their role, and the place of community pharmacies in the health care system in the context of-among others-the introduction and popularization of pharmaceutical care. Subsequently, these effor...

متن کامل

Pharmacy Practice and Education in the Czech Republic †

The PHARMINE ("Pharmacy Education in Europe") project studied the organisation of pharmacy education, practice and legislation in the European Union (EU) with the objectives of evaluating to what degree harmonisation had taken place with the EU, and producing documents on each individual EU member state. Part of this work was in the form of a survey of pharmacy education, practice, and legislat...

متن کامل

Physicochemical evaluation of lyophilized formulation of p-SCN-Bn-DOTA-and p-SCN-Bn-DTPA-rituximab for NHL radioimmunotherapy

Radioimmunotherapy (RIT) of Non-Hodgkin’s lymphoma (NHL) is said to be more advantageous compared to unlabelled therapeutic antibodies. To this date, radiolabelled murine anti-CD20 mAbs, Zevalin® and Bexxar® have been approved for imaging and therapy. A preparation containing rituximab, chimeric mAb radioimmunoconjugate suitable for Lu-177 labeling, could provide better imaging and therapeutic ...

متن کامل

Physicochemical evaluation of lyophilized formulation of p-SCN-Bn-DOTA-and p-SCN-Bn-DTPA-rituximab for NHL radioimmunotherapy

Radioimmunotherapy (RIT) of Non-Hodgkin’s lymphoma (NHL) is said to be more advantageous compared to unlabelled therapeutic antibodies. To this date, radiolabelled murine anti-CD20 mAbs, Zevalin® and Bexxar® have been approved for imaging and therapy. A preparation containing rituximab, chimeric mAb radioimmunoconjugate suitable for Lu-177 labeling, could provide better imaging and therapeutic ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014